Lync Bio Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $14.7M

  • Investors
  • 7

Lync Bio General Information

Description

Manufacturer of antibody-drug conjugates intended to advance therapies for autoimmune diseases and cancer. The company offers innovative drug research and clinical translation, enabling healthcare providers worldwide to address unmet patient needs.

Contact Information

Website
www.lyncbio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Creative Industry Park
  • Number 328 Xinghu Street, Suzhou Industrial Park
  • Suzhou, Jiangsu 201203
  • China
+86 158
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Manufacturing, Life Sciences, Oncology
Corporate Office
  • Creative Industry Park
  • Number 328 Xinghu Street, Suzhou Industrial Park
  • Suzhou, Jiangsu 201203
  • China
+86 158

Lync Bio Timeline

202420252026
Date FoundedFinancing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lync Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC 19-May-2026 $14.7M Completed Generating Revenue
4. Early Stage VC 04-Dec-2025 Completed Generating Revenue
3. Seed Round 17-Nov-2023 Completed Startup
2. Seed Round 25-Dec-2025 Completed Startup
1. Seed Round 04-Dec-2025 Completed Startup
To view Lync Bio’s complete valuation and funding history, request access »

Lync Bio Patents

  • 1

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 1

    Pending

  • Expiring in next 12 mo

Lync Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026175397-A1 Antibody-drug conjugates, linker-payloads, and uses thereof Pending 18-Feb-2025

Lync Bio Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
BioTrack Capital Venture Capital Minority
Apricot Capital (Shanghai) Venture Capital Minority
Lenovo Capital and Incubator Group Corporate Venture Capital Minority
Panlin Capital Venture Capital Minority
Elikon Venture Growth/Expansion Minority
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial

Lync Bio FAQs

  • When was Lync Bio founded?

    Lync Bio was founded in 2023.

  • Where is Lync Bio headquartered?

    Lync Bio is headquartered in Suzhou, China.

  • What industry is Lync Bio in?

    Lync Bio’s primary industry is Drug Discovery.

  • Is Lync Bio a private or public company?

    Lync Bio is a Private company.

  • What is Lync Bio’s current revenue?

    The current revenue for Lync Bio is .

  • How much funding has Lync Bio raised over time?

    Lync Bio has raised $28.7M.

  • Who are Lync Bio’s investors?

    BioTrack Capital, Apricot Capital (Shanghai), Lenovo Capital and Incubator Group, Panlin Capital, and Elikon Venture are 5 of 7 investors who have invested in Lync Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process